Asset Publisher

The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

Recognizing great ideas at the McGill Clinical Innovation Competition

Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!

Guidelines for managing anaphylaxis in children need an update

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet

The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity

Widespread off-label use of epilepsy medications could put some patients at risk

Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain

Drug-Resistant TB: A Clear and Present Danger

In two articles posted this week to Forbes, Dr. Madhukar Pai outlines the great threat posed by drug-resistant tuberculosis (DR-TB), while also offering a glimmer of hope.

Research Day for the IDIGH Program at the RI-MUHC is organized for and by trainees ... but everyone profits!

Nine awards were given across three presentation categories at the Fourth Annual Research Day of the Infectious Diseases and Immunity in Global Health Program

RI-MUHC researcher to receive new funding from GlycoNet

Dr. Don Sheppard`s project in collaboration with The Hospital for Sick Children aims to improve the health of Canadians while generating positive economic outcomes

Talking open science with Dr. Nitika Pant Pai

Dr. Nitika Pant Pai answers questions about her work with ScienceOpen and how it can benefit researchers and, ultimately, patients

Four Burning Questions for Madhukar Pai and Dick Menzies on World TB Day

Leading researchers at the McGill International TB Centre and RI-MUHC discuss the conditions that allow TB to flourish and the important role McGill and the RI-MUHC are playing to combat it.

Sasha Bernatsky interviewed on comorbidities and making informed choices

Sasha Bernatsky, MD, PhD, was interviewed by Gerald Major, President of the Canadian Spondylitis Association, at the Annual Canadian Rheumatology Association Meeting that took place in...

A second case of HIV remission

RI-MUHC researchers consulted on implications for HIV research

Researcher recognized by McGill University for media and public engagement in combatting a deadly disease

Dr. Madhukar Pai received the Principal’s Prize for Engagement through Media in the academic category from McGill University for helping to focus global attention on tuberculosis, the leading...

From Patient to Pipette: Unlocking the Insights of Rare Diseases

No diseases are irrelevant, clinician-scientist Donald Vinh explains

Dr. Marcel Behr elected to Fellowship in the AAM

Dr. Marcel Behr has been elected to an honorific leadership group within the American Academy for Microbiology.

Our Canadian Women Leaders in Global Health: Face to face with three extraordinary RI-MUHC scientists

Monday, February 11 is International Day of Women and Girls in Science

Viral communications hacking boosts Leishmania infections

New study sheds light on viral biology, could lead to efficient vaccines against a tropical disease

A hide-out for viruses in the testicles

RI-MUHC team leads an innovative study using testicular tissue to unlock the secrets of the immune system...

Dr. Sasha Bernatsky receives Arthritis Alliance of Canada Award

Dr. Sasha Bernatsky, Professor in the Department of Medicine at McGill University’s Faculty of Medicine, is the recipient of...

Confronting a killer

Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...

See Archive - IDIGH